Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1118 of 5804
-
New study tests fasting and Weight-Loss drugs to shield hearts during prostate cancer treatment
Disease control Recruiting nowThis phase II trial compares the effect of time-restricted eating (TRE) and glucagon-like peptide-1 (GLP1) receptor agonists (RA), semaglutide and tirzepatide, to an American Heart Association (AHA) heart healthy diet (HHD) intervention on heart and blood vessel health (cardiovas…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New study pumps chemo directly to liver, lets patients skip hospital visits
Disease control Recruiting nowThe goal of this clinical trial is to help learn about the safety and feasibility of hepatic artery infusion chemotherapy for those who have colorectal liver metastases, both resectable and unresectable, or unresectable intrahepatic cholangiocarcinoma. The main questions it aims …
Phase: PHASE2 • Sponsor: Michael J Cavnar, MD • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could a common drug make head and neck cancer treatment more effective?
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of decitabine in combination with standard of care surgery, radiation, and/or chemotherapy and the effectiveness of the combination in treating patients with head and neck squamous cell cancers that are not caused b…
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New drug LB-102 aims to lift bipolar depression
Symptom relief Recruiting nowPhase II study for patients with Bipolar 1 Disorder experiencing major depressive episode. Patient eligible for enrollment will be randomized (like flipping a coin) to either active drug (LB-102 or placebo). Treatment is for 6 weeks.
Phase: PHASE2 • Sponsor: LB Pharmaceuticals Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
AI helps pacemaker find the sweet spot for failing hearts
Disease control Recruiting nowThe purpose of this study is to compare the effectiveness of AI-guided LBBAP versus conventional LBBAP (not AI-guided) in improving CRT response rates and clinical outcomes.
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could a Ketamine-Like drug ease OCD? new trial underway
Symptom relief Recruiting nowThe purpose of this study is to understand how RR-HNK works in the brain to bring about a reduction in OCD symptoms.
Phase: PHASE1, PHASE2 • Sponsor: Carolyn Rodriguez • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New hope for lung scarring: ABBV-142 enters Mid-Stage trial
Disease control Recruiting nowIdiopathic Pulmonary Fibrosis (IPF) is a rare, long-lasting lung disease that causes scarring of lung tissue, shortness of breath, and loss of lung function. IPF leads to significant loss of quality of life and shortened lifespan. This study is a platform study evaluating differe…
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Experimental combo aims to tackle tough bone cancer
Disease control Recruiting nowThe goal of this clinical trial is to define the maximum tolerated dose (MTD) and/or Recommended phase 2 dose (RP2D) of Tegavivint in combination with Gemcitabine in patients with relapsed or refractory osteosarcoma (OS). The study will also investigate the toxicities of Tegaviv…
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New ultrasound technique could sharpen ovarian cancer detection
Diagnosis Recruiting nowThis clinical trial studies how well ultrasound microvessel imaging (UMI) works in evaluating ovarian and adnexal lesions in patients who are scheduled to have surgical treatment for their ovarian or adnexal lesions as part of their clinical care. Ovarian cancer is the most letha…
Phase: NA • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
New cancer pill TQB3122 enters first human tests
Disease control Recruiting nowThis is the first-in-human clinical study of TQB3122, aiming to evaluate the safety, tolerability, and pharmacokinetic characteristics of TQB3122 in advanced solid tumors, and to preliminarily explore its efficacy in solid tumors.
Phase: PHASE1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Heart ablation before ICD may prevent deadly rhythms in High-Risk patients
Disease control Recruiting nowThis prospective, multicenter, open-label, randomized-controlled trial compares two treatment strategies in high-risk ischemic cardiomyopathy (ICM) patients referred for primary ICD implantation. Participants will be randomized to receive either prophylactic VT ablation within th…
Phase: NA • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New pill could ease iron overload for thousands with genetic disorder
Disease control Recruiting nowThis is a phase 2, multicenter, randomized, placebo-controlled, double-blind, parallel-group, proof-of-concept study to assess vamifeport in adult participants with homeostatic iron regulator gene-related hereditary hemochromatosis (HFE-HH). The primary objective of the study is …
Phase: PHASE2 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New PET dye could spot Alzheimer's early in the brain
Diagnosis Recruiting nowThis study is to evaluate the efficacy and safety of \[18F\]-APN-1607 Injection in PET imaging for detecting AD-related cognitive impairment.
Phase: PHASE3 • Sponsor: JYAMS PET Research & Development Limited • Aim: Diagnosis
Last updated Jun 27, 2026 09:07 UTC
-
Brain zaps + treadmill training may sharpen stroke recovery
Symptom relief Recruiting nowThis randomized, double-blind, placebo-controlled trial will investigate whether repetitive transcranial magnetic stimulation (rTMS) applied to the dorsolateral prefrontal cortex (DLPFC) can enhance the effects of dual-task gait training in people with chronic stroke. Participant…
Phase: NA • Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
New therapy hopes to ease complex PTSD in refugees
Symptom relief Recruiting nowIn WHO ICD-11 (its latest edition), the diagnostic criteria for post-traumatic stress disorder (PTSD) were revised, and a new sibling disorder, complex post-traumatic stress disorder (CPTSD) was introduced. CPTSD is a debilitating condition associated with severe, prolonged, or c…
Phase: NA • Sponsor: Eva Heim • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Vitamin e dressing may speed healing of bedsores
Disease control Recruiting nowThe goal of this clinical trial is to investigate the effects of the dressing containing Tocotrienols on patients with stage 1 and stage 2 pressure ulcers. The main questions it aims to answer are: * Will the dressing containing Tocotrienols lead to a reduction in the Pressure U…
Phase: NA • Sponsor: Monash University Malaysia • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Brain training may ease 'Long COVID' fog in seniors
Symptom relief Recruiting nowThe goal of this clinical trial is to determine if a neuroscience-based computerized cognitive remediation ("brain training") program can treat neurocognitive dysfunction (i.e., memory or thinking difficulties) that emerges in some older adults following a viral infection. The ma…
Phase: NA • Sponsor: Cutter Lindbergh • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Can a daily pill stop leukemia relapse after transplant?
Disease control Recruiting nowThe purpose of the study is to see if a study drug called asciminib is safe and okay for people to take after they've had treatment for a type of blood cancer called Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ B-ALL). We're looking at two groups of adults:…
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New dissolvable stent could keep nasal polyps away after surgery
Disease control Recruiting nowThis study consists of two parts evaluating the efficacy and safety of a fully degradable sinus drug-eluting stent in patients with eosinophilic chronic rhinosinusitis with nasal polyps (ECRSwNP). Part A assesses the efficacy and safety of the stent when used immediately after f…
Phase: NA • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New eye drops aim to halt worsening nearsightedness in kids
Disease control Recruiting nowAxial myopia is a type of nearsightedness that happens when the eye is too long from front to back. This causes distant vision to be blurry. Axial myopia tends to start during childhood and worsens over time (as the eyes continue to grow longer). This can lead to serious eye-rela…
Phase: PHASE2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC